[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-661586-105":59,"doc-detail-661586-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oecd-health-working-papers-no-171-exploring-the-feasibility-of-sharing-information-on-medicine-prices-across-countries","OECD Health Working Papers No. 171 - Exploring the feasibility of sharing information on medicine prices across countries","","Debates on pharmaceutical policy increasingly emphasise greater transparency, including for medicine prices. Against this backdrop, a resolution of the 72nd World Health Assembly called for enhanced transparency and the Organisation of the Oslo Medicines Initiative. Despite strong collective interest in improving price transparency, the document examines what can realistically and feasibly be shared across countries and under which conditions for different types of price information.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oecd-health-working-papers-no-171-exploring-the-feasibility-of-sharing-information-on-medicine-prices-across-countries/661586/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oecd-health-working-papers-no-171-exploring-the-feasibility-of-sharing-information-on-medicine-prices-across-countries/661586.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-10-28",true,{"@type":102,"interactionType":103,"userInteractionCount":8},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What policy debate motivates the paper’s focus on medicine price transparency?","Question",{"text":112,"@type":113},"The paper is motivated by debates on pharmaceutical policy that increasingly stress the need for more transparency, including around medicine prices.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What international actions are referenced regarding transparency and price information?",{"text":117,"@type":113},"It references a resolution of the 72nd World Health Assembly and the Organisation of the Oslo Medicines Initiative, both calling for greater transparency.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the main feasibility question the paper addresses?",{"text":121,"@type":113},"It evaluates what can and can be feasibly shared across countries regarding different types of medicine price information and under what conditions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},661586,1793170782,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":8,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":129,"read_time":144},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","OECD Health Working Papers No. 171  \nExploring the feasibility of sharing information on medicine prices across countries  \nMarjolijn Moens, Eliana Barrenho, Valérie Paris  \n[https://dx.doi.org/10.1787/5e4a7a47-en](https://dx.doi.org/10.1787/5e4a7a47-en)  \nOECD Health Working Papers No.171  \nExploring the feasibility of sharing information on medicine prices across  \ncountries  \nJEL classification: F6,H51,H57,I11,I18,K12,K23,K32,L1,L65 .  \nAuthorised for publication by Stefano Scarpetta, Director, Directorate for Employment, Labour and Social Affairs Marjolijn Moens*, Eliana Barrenho*, Valérie Paris*  \nThis cancel and replace is issued to correct a graph on page 39. Cancel & replaces the same document of 7 November 2024.  \nOECD Health Working papers  \n[https://www.oecd.org/els/health-systems/health-working-papers.htm](https://www.oecd.org/els/health-systems/health-working-papers.htm)  \nOECD Working Papers should not be reported as representing the official views of the OECD or of its member countries. The opinions expressed and arguments employed are those of the author(s) .  \nWorking Papers describe preliminary results or research in progress by the author(s) and are published to stimulate discussion on a broad range of issues on which the OECD works. Comments on Working Papers are welcomed and may be sent to [health.contact@oecd.org](health.contact@oecd.org/els.contact@oecd.org)[/](health.contact@oecd.org/els.contact@oecd.org)[els.contact@oecd.org](health.contact@oecd.org/els.contact@oecd.org).  \nThis document and any map included herein are without prejudice to the status of or sovereignty over any territory, to the delimitation of international frontiers and boundaries and to the name of any territory, city or area.  \nThe statistical data for Israel are supplied by and under the responsibility of the relevant Israeli authorities. The use of such data by the OECD is without prejudice to the status of the Golan Heights, East Jerusalem and Israeli settlements in the West Bank under the terms of international law.  \nNote by the Republic of Türkiye  \nThe information in this document with reference to “Cyprus” relates to the southern part of the Island. Thereis no single authority representing both Turkish and Greek Cypriot people on the Island. Türkiye recognises the Turkish Republic of Northern Cyprus (TRNC) . Until a lasting and equitable solution is found within the context of the United Nations, Türkiye shall preserve its position concerning the “Cyprus issue”.  \nNote by all the European Union Member States of the OECD and the European Union:  \nThe Republic of Cyprus is recognised by all members of the United Nations with the exception of Türkiye. The information in this document relates to the area under the effective control of the Government of the Republic of Cyprus.  \nAttribution 4.0 International (CC BY 4.0)  \nThis work is made available under the Creative Commons Attribution 4.0 International licence. By using this work, you accept to be bound by the terms of this licence  \n([https://creativecommons.org/licenses/by/4.0).](https://creativecommons.org/licenses/by/4.0).)[ ](https://creativecommons.org/licenses/by/4.0).)[Attribution](Attribution) – you must cite the work.  \nTranslations – you must cite the original work, identify changes to the original and add the following text: In the event of any discrepancy between the original work and the translation, only the text of original work should be considered valid.  \nAdaptations – you must cite the original work and add the following text: This is an adaptation of an original work by the OECD. The opinions expressed and arguments employed in this adaptation should not be reported as representing the official views of the OECD or of its Member countries.  \nThird-party material – the licence does not apply to third-party material in the work. If using such material, you are responsible for obtaining permission from the third party and for any claims of infringement.  \nYou","cbCaimZ1FBRRNZyf","https://ap.wps.com/l/cbCaimZ1FBRRNZyf","pdf",1650208,65,"English","# Abstract\n## Publication and licensing notes\n## International and institutional disclaimers\n## Attribution 4.0 International (CC BY 4.0)","[{\"question\":\"What policy debate motivates the paper’s focus on medicine price transparency?\",\"answer\":\"The paper is motivated by debates on pharmaceutical policy that increasingly stress the need for more transparency, including around medicine prices.\"},{\"question\":\"What international actions are referenced regarding transparency and price information?\",\"answer\":\"It references a resolution of the 72nd World Health Assembly and the Organisation of the Oslo Medicines Initiative, both calling for greater transparency.\"},{\"question\":\"What is the main feasibility question the paper addresses?\",\"answer\":\"It evaluates what can and can be feasibly shared across countries regarding different types of medicine price information and under what conditions.\"}]","OECD Health Working Papers No. 171 - Exploring the feasibility of sharing information on medicine prices across countries | PDF",164]